Impact of transcranial direct current stimulation on cognitive function, brain functional segregation, and integration in patients with mild cognitive impairment according to amyloid-beta deposition and APOE ε4-allele
Abstract Background: Anodal transcranial direct current stimulation (anodal-tDCS) is known to improve cognition and normalise abnormal network configuration during resting-state functional magnetic resonance imaging (fMRI) in patients with mild cognitive impairment (MCI). We evaluated the impact of sequential anodal-tDCS on cognitive functions, functional segregation, and integration parameters in patients with MCI, according to high-risk factors for Alzheimer’s disease (AD): amyloid-beta (Aβ) deposition and APOE ε4-allele status. Methods: In 32 patients with MCI ([18F] flutemetamol-: n = 10, [18F] flutemetamol+: n = 22; APOE ε4-: n = 13, APOE ε4+: n = 19), we delivered anodal-tDCS (2 mA/day, five times/week, for 2 weeks) over the left dorsolateral prefrontal cortex and assessed the neuropsychological test battery and resting-state fMRI measurements before and after 2 weeks’ stimulation.Results: We observed a trend for impact of an anodal-tDCS-by-Aβ retention interaction on MMSE score changes. Baseline Aβ accumulation tended to be negatively associated with word list recognition score changes. We found a significant effect of tDCS-by-APOE ε4-allele interaction on changes in the functional segregation parameter of the temporal pole. Baseline Aβ deposition associated negatively with change in global functional integrity of hippocampal formation. There was a significant difference in brain functional segregation and integration parameters between MCI patients with and without high-risk factors of AD.Conclusions: Thus, anodal-tDCS could help to improve cognitive function and enhance restorative and compensatory intrinsic functional changes in MCI patients, modulated by the presence of Aβ retention and the APOE ε4-allele. Trial registration: This study is registered with the Clinical Research Information Service of Korea Disease Control and Prevention Agency (KCT0006020). Registered on 24 March 2021—retrospectively registered.